A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study evaluated a blood sugar lowering insulin, LY900014, delivered by an insulin pump continuously under the skin. The study was conducted in participants with type 1 diabetes mellitus to investigate how the human body processed LY900014 and its effect on blood sugar levels when it was delivered via an insulin pump. Side effects and tolerability were be documented.
Epistemonikos ID: e9bc19351828c47d15f036cd84ab805591be2645
First added on: May 12, 2024